MARKET

TLGT

TLGT

Teligent Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.4027
-0.0103
-2.49%
Closed 16:00 01/17 EST
OPEN
0.4180
PREV CLOSE
0.4130
HIGH
0.4180
LOW
0.3950
VOLUME
666.72K
TURNOVER
--
52 WEEK HIGH
1.900
52 WEEK LOW
0.3900
MARKET CAP
21.69M
P/E (TTM)
-0.6333
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of TLGT and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

TLGT News

  • FDA seeks more data before making decision on South Jersey pharma firm's generic drug
  • American City Business Journals.12/26/2019 18:23
  • The Daily Biotech Pulse: NewLink Genetics Licenses Ovarian Cancer Dug, Correvio Awaits FDA Verdict
  • Benzinga.12/24/2019 12:24
  • The Daily Biotech Pulse: NewLink Genetics Licenses Ovarian Cancer Dug, Correvio Awaits FDA Verdict
  • Benzinga.12/24/2019 12:24
  • Teligent, Inc. Receives CRL From FDA Requesting Further Data On Complex Drug
  • Benzinga.12/23/2019 22:13

More

Industry

Pharmaceuticals
+0.13%
Pharmaceuticals & Medical Research
+0.06%

Hot Stocks

Name
Price
%Change

About TLGT

Teligent, Inc. is a specialty generic pharmaceutical company. Under the Company's own label, it markets and sells generic injectable pharmaceutical products in the United States and Canada. In the United States it marketed 16 generic topical pharmaceutical products and four branded generic pharmaceutical products, as of December 31, 2016. It provides development, formulation and manufacturing services to the pharmaceutical, over-the-counter (OTC) and cosmetic industries. It focuses on developing, manufacturing and marketing a portfolio of generic pharmaceutical products under its own label in topical, injectable, complex and ophthalmic dosage forms, and managing its contract manufacturing and formulation services business. Its pipeline included 34 Abbreviated New Drug Application(ANDAs) filed with the United States Food and Drug Administration (FDA) for additional pharmaceutical products, as of December 31, 2016.
More

Webull offers Teligent Inc (TLGT) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.